stars 1 stars 2 stars 3

Our mission Kejako, in the field of ophthalmology, merge Medtech and Engineering expertise to develop solution for interested presbyopic patients seeking to keep quality of life through the compensation of visual accommodation decay. We address presbyopia with an anti-aging mindset to treat the gradual loss of visual accommodation. Our promise, unlike any other existing surgical solution, is to provide non-invasive (ultra-minimally invasive or a “no-cut”) laser solution to delay the need for reading glasses without compromising the patient’s quality of vision. Our solution will be fully personalized to the patient by using our simulation expertise which is already recognized by our peers as we provide simulation services to strategic partners. We have the potential to become the next generation standard of care in personalized ophthalmic anti-aging medicine. Our company Kejako is privately held company based in Switzerland and Saint-Étienne and financed since March 2015

Kejako Questions

The Kejako annual revenue was $1 million in 2026.

Kejako is based in Saint-Étienne, Auvergne-Rhône-Alpes.

The NAICS codes for Kejako are [33, 339].

The SIC codes for Kejako are [384, 38].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users